JishuKingkarDasMD

Hospital Medicine/Hospitalist

Physician

Dr. Das is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
410 W 10th Ave
Columbus, OH 43210
Phone+1 614-293-7499

Fax+1 614-366-2360

I am a board certified Internal Medicine hospitalist. I have 7 years of experience working in tertiary care hospitals taking care of complex patients from diverse backgrounds. I am looking for either a full time hospitalist or a traditional clinic practice with in- hospital or ER time.

Western Michigan University Homer Stryker MD School of MedicineResidency, Internal Medicine, 2009 - 2012
Guwahati Medical CollegeClass of 1999

PubMed

2 citations
Perceived Stress, Knowledge, and Preventive Behaviors in Indian versus US-based Participants During COVID-19: A Survey Study.
Ankita Sinharoy, Shekhar Pal, Jishu Das, Pritish Mondal
Frontiers in Public Health. 2021-09-13
3 citations
Clinical Course of Hypertrophic Pulmonary Osteoarthropathy in a Patient Receiving Immune Checkpoint Inhibitor Therapy.
Andrew Johns, Chad Sorenson, Alan Rogers, Julia L. Agne, Desmond M. D’Souza
Clinical Lung Cancer. 2020-01-27
2 citations
The Association Between Female Smoking and Childhood Asthma Prevalence-A Study Based on Aggregative Data.
Vishal Midya, Shekhar Pal, Ankita Sinharoy, Jishu Das, Harish Rao
Frontiers in Public Health. 2018-10-17

Journal Articles

Incidence of Ototoxicity in Head and Neck Cancer (HNSCC) Patients (pts) Receiving Concomitant Chemo-Radiation (CRT) with Weekly or Triweekly Cisplatin (Cis)
Das J, Custer A, Blakaj D, Old M, Songzhu Z, Bhatt A, Kang S, Agrawal A, Ozer E, Wobb J, Rupert R, Mitchell D, Brock G, Verschraegen C, Rocco J, Bonomi M, J Clin Oncol, 1/1/2018
Clinical and immune effects of cetuximab and weekly low dose carboplatin and paclitaxel in head and neck cancer patients with poor performance status
Marcelo Raul Bonomi, Brett Klamer, Tamjeed Ahmed, Safoa Ado, Mitra Kooshki, Jishu Das, Guy Brock, Triozzi Pierre, J Clin Oncol, 1/1/2018

Books/Book Chapters

Tropical Pediatrics- A Public Health Concern of International Proportions
Chapter: Snake Bites
Page 129 - 144Jishu Das, Richard Roach

Abstracts/Posters

Incidence of Ototoxicity in Head and Neck Cancer (HNSCC) Patients (pts) Receiving Concomitant Chemo-Radiation (CRT) with Weekly or Triweekly Cisplatin (Cis).
Das J, Custer A, Blakaj D, Old M, Songzhu Z, Bhatt A, Kang S, Agrawal A, Ozer E, Wobb J, Rupert R, Mitchell D, Brock G, Verschraegen C, Rocco J, Bonomi M, American Society of Clinical Oncology Annual Meeting, 1/1/2018

Lectures

Incidence of ototoxicity in head and neck cancer (HNSCC) patients (pts) receiving concomitant chemo-radiation (CRT) with weekly or triweekly cisplatin (Cis).
2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018